These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3001753)

  • 1. Endogenous sodium-potassium pump inhibitor in low renin hypertension.
    Haddy FJ; Pamnani MB
    Prog Clin Biol Res; 1985; 192():205-12. PubMed ID: 3001753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of a humoral Na+ -K+ pump inhibitor in low renin hypertension.
    Haddy FJ; Pamnani MB
    Klin Wochenschr; 1985; 63 Suppl 3():78-81. PubMed ID: 3889488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a circulating endogenous Na+-K+ pump inhibitor in low-renin hypertension.
    Haddy FJ; Pamnani MB
    Fed Proc; 1985 Sep; 44(12):2789-94. PubMed ID: 2411605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of a humoral sodium-potassium pump inhibitor in low-renin hypertension.
    Haddy FJ; Pamnani MB
    Fed Proc; 1983 Jul; 42(10):2673-80. PubMed ID: 6345202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of the natriuretic hormone to essential hypertension.
    de Wardener HE; MacGregor GA
    Postgrad Med J; 1983; 59 Suppl 2():74-7. PubMed ID: 6310538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral factors and the sodium-potassium pump in low renin hypertension.
    Haddy FJ
    Klin Wochenschr; 1982 Oct; 60(19):1254-7. PubMed ID: 6292571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a circulating sodium-potassium pump inhibitor in low renin hypertension.
    Haddy FJ; Pamnani MB
    Clin Exp Hypertens A; 1985; 7(5-6):633-45. PubMed ID: 3893806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Affinity chromatographic study of the changes in the endogenous Na+-K+-ATPase inhibitor during sodium loading in man].
    Cloix JF; Henning G; Crabos M; Delva P; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1251-5. PubMed ID: 6098236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periventricular forebrain mechanisms for blood pressure regulation.
    Buggy J; Huot S; Pamnani M; Haddy F
    Fed Proc; 1984 Jan; 43(1):25-31. PubMed ID: 6360715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].
    de Wardener H
    Nephrologie; 1987; 8(1):3-6. PubMed ID: 3035398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
    Pernollet MG; de Thé H; Delva P; Wauquier I; Devynck MA; Baudouin-Legros M; Deray G; Rosenfeld J; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
    Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic factor modulates the plasma levels of a Na+/K+ATPase inhibitor in volume expanded borderline hypertensives.
    Borghi C; Boschi S; Costa FV; Ambrosioni E
    Am J Hypertens; 1991 Jul; 4(7 Pt 1):618-22. PubMed ID: 1651740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous inhibitors of the Na,K pump.
    Doris PA
    Miner Electrolyte Metab; 1996; 22(5-6):303-10. PubMed ID: 8933501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of a humoral Na+,K+-ATPase inhibitor in regulating precapillary vessel tone.
    Haddy FJ
    J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S439-56. PubMed ID: 6206353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Affinity chromatography for the detection of human endogenous inhibitor of NA+, K+ -ATPase].
    Henning G; Cloix JF
    C R Seances Acad Sci III; 1983; 297(6):295-8. PubMed ID: 6318931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
    J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.